Prestige Biologics (Korea) Today
| 334970 Stock | KRW 4,030 5.00 0.12% |
PerformanceVery Weak
| Odds Of DistressBelow Average
|
Prestige Biologics is trading at 4030.00 as of the 23rd of March 2025, a 0.12% down since the beginning of the trading day. The stock's open price was 4035.0. Prestige Biologics has about a 34 percent probability of financial distress in the next few years of operation and has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 23rd of December 2024 and ending today, the 23rd of March 2025. Click here to learn more.
Prestige Biologics Co., Ltd. specializes in the development and production of biologic agents and biosimilars. The company was founded in 2015 and is based in Cheongju-si, South Korea. Prestige Biologics is traded on Korean Securities Dealers Automated Quotations in South Korea. More on Prestige Biologics Co
Moving together with Prestige Stock
Moving against Prestige Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Prestige Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Prestige Biologics' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Prestige Biologics or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Biotechnology, Healthcare (View all Sectors) |
Prestige Biologics Co (334970) is traded on KOSDAQ in Korea . The company currently falls under 'Mega-Cap' category with a current market capitalization of 198.91 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Prestige Biologics's market, we take the total number of its shares issued and multiply it by Prestige Biologics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Prestige Biologics operates under Healthcare sector and is part of Biotechnology industry.
Prestige Biologics Co has accumulated about 36.77 B in cash with (25.87 B) of positive cash flow from operations.
Check Prestige Biologics Probability Of Bankruptcy
Prestige Biologics Risk Profiles
Although Prestige Biologics' alpha and beta are two of the key measurements used to evaluate Prestige Biologics' performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.01 | |||
| Standard Deviation | 2.82 | |||
| Variance | 7.98 | |||
| Risk Adjusted Performance | (0.07) |
Prestige Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Prestige Biologics without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Performance Analysis Now
Performance AnalysisCheck effects of mean-variance optimization against your current asset allocation |
| All Next | Launch Module |
Other Information on Investing in Prestige Stock
Prestige Biologics financial ratios help investors to determine whether Prestige Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Prestige with respect to the benefits of owning Prestige Biologics security.